Showing 431-440 of 2891 results for "".
MATV News Extra: Daxxify Q&A with Dr. Jeffrey Dover
https://modernaesthetics.com/series/matv-news/matv-news-extra-daxxify-qa-with-dr-jeffrey-dover/33704/The FDA has approved Revance Therapeutics’ Daxxify (daxibotulinumtoxinA-lanm) for injection for the temporary improvement of moderate to severe glabellar lines in adults. Dermatologists and clinical trial investigator Jeffrey Dover, MD sat down with MATV News to share insights into the SAKURA PhaseUnderstanding and Treating Estrogen Deficient Skin: A Panel Discussion About an Entirely New Category of Skin Care
https://modernaesthetics.com/ma-supplements/2019-june-may-supplement/understanding-and-treating-estrogen-deficient-skin-a-panel-discussion-about-an-entirely-new-category-of-skin-care/33964/Biopelle, Inc. has launched Emepelle, the first and only clinically proven skin care line that safely and effectively helps address estrogen deficient skin (EDS) with revolutionary, new MEP Technology™. To coincide with the launch, a panel of leading dermatologists convened recently to discuss the pPutting Your Aesthetic Practice on The Map
https://modernaesthetics.com/ma-issues-index/2023-may-june/putting-your-aesthetic-practice-on-the-map/35284/Google Maps is the key to local search optimization success.Top 10 Takeaways Every IV Vitamin Therapy Practice Should Know About the Recent Revisions in USP 797
https://modernaesthetics.com/topics/practice-development/top-10-takeaways-every-iv-vitamin-therapy-practice-should-know-about-the-recent-revisions-in-usp-797/35262/Review the steps necessary to remain USP 797 compliant.Board Forum: What Do You Predict for Leg Aesthetics This Year?
https://modernaesthetics.com/ma-issues-index/2021-mar-apr/board-forum-what-do-you-predict-for-leg-aesthetics-this-year/35025/After a “summerless” 2020, technology paves the way for new opportunities in 2021.Catching Up With Botox Cosmetic's Newest Spokesperson Actress Jenny Mollen
https://modernaesthetics.com/ma-issues-index/2019-nov-dec/catching-up-with-botox-cosmetics-newest-spokesperson-actress-jenny-mollen/34833/Modern Aesthetics® chats with actress Jenny Mollen and her derm BFF Patricia Wexler, MDEditorial Board Forum: Can We Avoid The Commoditization Of Aesthetic Medicine?
https://modernaesthetics.com/ma-issues-index/2013-jan-feb/editorial-board-forum-can-we-avoid-the-commoditization-of-aesthetic-medicine/34799/Leaders in the field of aesthetics tell how they respond to non-core competition, the surge of price negotiating patients, and the challenges of branding oneself as an expert.The Next Big Thing: How To Spot It and Avoid the Imitators
https://modernaesthetics.com/ma-issues-index/2013-mar-apr/the-next-big-thing-how-to-spot-it-and-avoid-the-imitators/34784/A true TNBT can enhance our business from a financial and clinical standpoint. A fake can have dire effects on patient trust and long-term success.Assessing the Skin Care Opportunity
https://modernaesthetics.com/ma-issues-index/2015-july-aug/assessing-the-skin-care-opportunity/34491/No longer nebulous “lotions and potions,” today's high-quality cosmeceuticals are delivering results for patients—and practices.Equipment Financing vs. a Traditional Loan: What’s Best for My Business?
https://modernaesthetics.com/topics/energy-based-devices/equipment-financing-vs-a-traditional-loan-whats-best-for-my-business/35130/It’s beneficial to weigh all your options for financing a large expense